DE69824326D1 - Pharmazeutische Emulsion enthaltend Sorbinsäure, Na-EDTA und Borsäure - Google Patents

Pharmazeutische Emulsion enthaltend Sorbinsäure, Na-EDTA und Borsäure

Info

Publication number
DE69824326D1
DE69824326D1 DE69824326T DE69824326T DE69824326D1 DE 69824326 D1 DE69824326 D1 DE 69824326D1 DE 69824326 T DE69824326 T DE 69824326T DE 69824326 T DE69824326 T DE 69824326T DE 69824326 D1 DE69824326 D1 DE 69824326D1
Authority
DE
Germany
Prior art keywords
emulsion
pharmaceutically acceptable
boric acid
acid
sorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69824326T
Other languages
English (en)
Other versions
DE69824326T2 (de
Inventor
Masazumi Yamaguchi
Masayo Yamaguchi
Katsuhiro Inada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69824326D1 publication Critical patent/DE69824326D1/de
Publication of DE69824326T2 publication Critical patent/DE69824326T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69824326T 1997-02-28 1998-02-25 Pharmazeutische Emulsion enthaltend Sorbinsäure, Na-EDTA und Borsäure Expired - Lifetime DE69824326T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4654897 1997-02-28
JP4654897 1997-02-28

Publications (2)

Publication Number Publication Date
DE69824326D1 true DE69824326D1 (de) 2004-07-15
DE69824326T2 DE69824326T2 (de) 2005-06-16

Family

ID=12750377

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824326T Expired - Lifetime DE69824326T2 (de) 1997-02-28 1998-02-25 Pharmazeutische Emulsion enthaltend Sorbinsäure, Na-EDTA und Borsäure

Country Status (6)

Country Link
US (1) US6379688B2 (de)
EP (1) EP0861658B1 (de)
KR (1) KR19980071702A (de)
AT (1) ATE268590T1 (de)
CA (1) CA2230805A1 (de)
DE (1) DE69824326T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
DE102004045622A1 (de) * 2004-09-17 2006-03-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Konservierungsmittel-Zusammensetzungen
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US20090074881A1 (en) * 2006-05-02 2009-03-19 Bioneutral Laboratories Corporation Usa Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof
CN101500541B (zh) * 2006-08-11 2011-06-15 旭化成化学株式会社 含有水难溶性药物的球状素颗粒的制造方法
CA2685230C (en) 2007-05-04 2012-10-16 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
CN102370617B (zh) * 2010-08-13 2013-09-11 中国科学院上海药物研究所 石杉碱甲眼用微乳制剂及其制备方法
EP2630952A1 (de) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Selbstkonservierende Öldispersionen enthaltend Borsäure
US20150374820A1 (en) * 2013-02-15 2015-12-31 Senju Pharmaceutical Co., Ltd. Difluprednate emulsion composition containing zinc
KR20170113568A (ko) 2015-02-06 2017-10-12 알.피.쉐러 테크놀러지즈 엘엘씨 폴리머 안정화된 약학 제제용 수중 유 에멀전의 제조
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
FR3104961B1 (fr) * 2019-12-20 2022-03-25 Oreal Composition cosmetique comprenant au moins un polyol comportant au moins trois fonctions hydroxy et au moins un ester de sorbitan polyoxyethylene
GB202013645D0 (en) * 2020-08-31 2020-10-14 Innotesto Bvba Pharmacetical compositions for the nasal administration of a colbalamin compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911107A (en) 1972-12-18 1975-10-07 Flow Pharma Inc Iodine composition and dissipating solution
US4031209A (en) 1972-12-18 1977-06-21 Flow Pharmaceuticals, Inc. Aqueous solution suitable for dissipating available iodine contained in an iodophor
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
DE2537303C3 (de) * 1975-06-02 1980-03-13 Flow Pharmaceuticals, Inc., Palo Alto, Calif. (V.St.A.) Sterile wäßrige Lösung für die Abgabe oder Verteilung von verfügbarem Jod und deren Verwendung
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
JPH0737381B2 (ja) * 1987-05-15 1995-04-26 参天製薬株式会社 ビタミンｅ水性製剤
DE3917109A1 (de) * 1989-05-26 1990-12-06 Anasco Gmbh Mittel zur bekaempfung des schnarchens
JP3090353B2 (ja) 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
BR9306399A (pt) 1992-05-22 1998-09-15 Senju Pharma Co Composição farmacéutica para uso no tratamento de glaucoma
JP2811036B2 (ja) 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンｅ点眼剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
JPH08133967A (ja) * 1994-11-02 1996-05-28 Eisai Co Ltd ドライアイ治療剤
JPH08193024A (ja) * 1995-01-17 1996-07-30 Ikeda Mohandou:Kk 点眼剤組成物

Also Published As

Publication number Publication date
DE69824326T2 (de) 2005-06-16
US6379688B2 (en) 2002-04-30
KR19980071702A (ko) 1998-10-26
CA2230805A1 (en) 1998-08-28
EP0861658A1 (de) 1998-09-02
EP0861658B1 (de) 2004-06-09
ATE268590T1 (de) 2004-06-15
US20010003003A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DE69824326D1 (de) Pharmazeutische Emulsion enthaltend Sorbinsäure, Na-EDTA und Borsäure
ES2098226T3 (es) Soluciones oftalmicas acuosas y metodo para conservarlas.
FI20055562A (fi) Alfa-interferonin stabiilit vesiliuosformulaatit
BR0215216A (pt) Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii
EA199900749A1 (ru) Фармацевтическая композиция
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
RU94046143A (ru) Фармацевтическая композиция для лечения глаукомы
KR940013505A (ko) 항 알레르기 점안제
KR950031084A (ko) 국소용 진양(鎭洋) 조성물
NO944956L (no) Preparat for lokal anvendelse, fremgangsmåte for fremstilling av slike, samt anvendelse av disse
KR880003211A (ko) 콘택트 렌즈의 처리 방법
JPS6452727A (en) Antiallergic eye drop
RU2001112458A (ru) Питательная среда для выделения bacillus cereus
KR920017637A (ko) 오일 프리 파운데이션 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition